Point72 Asset Management L.P. 13D and 13G filings for Prometheus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:27 pm Purchase |
2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
Point72 Asset Management L.P. | 3,114,107 6.700% |
1,131,546 (+57.07%) |
Filing |
| 2022-02-14 4:35 pm Sale |
2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
Point72 Asset Management L.P. | 1,982,561 5.100% |
-665,463 (-25.13%) |
Filing |
| 2021-03-22 5:02 pm Purchase |
2021-03-16 | 13G | Prometheus Biosciences, Inc. RXDX |
Point72 Asset Management L.P. | 2,648,024 6.800% |
2,648,024 (New Position) |
Filing |